Prognostic factors influencing morbidity and mortality in esophageal carcinoma
- PMID: 12436175
- DOI: 10.1590/s0041-87812002000500002
Prognostic factors influencing morbidity and mortality in esophageal carcinoma
Abstract
Purpose: In 1980, operative mortality for esophageal resection was 29%. Over the last 15 years, technical and critical care improvements contributed to the reduction of postoperative mortality rate to 8%. The aim of this study is to analyze retrospectively the role of different factors (surgical procedure, stage of the disease, and anesthetic risk) on the postoperative mortality of 63 patients that underwent esophagectomy with gastric interposition for cancer.
Methods: Seventy-two patients underwent esophagectomy. The stomach was the esophageal substitute in 63 cases. Surgical procedures included transthoracic esophagectomy in 49 patients and transhiatal esophagectomy in 14 cases. Among the 49 transthoracic esophagectomy patients, there were 18 patients with a high anesthetic risk (ASA III). Among the patients that underwent transhiatal esophagectomy, there were 10 patients with a high anesthetic risk (ASA III).
Results: The operative mortality rate was 14% (2/14) in transhiatal esophagectomy group and 22% (1(1/4)9) in transthoracic esophagectomy group (P = ns). The postoperative mortality of patients with a high anesthetic risk (ASA III) was 47% (8/17) after transthoracic esophagectomy and 10% (1/10) after transhiatal esophagectomy (P <0.05).
Discussion: In our experience, the operative mortality was nearly 18% (16.6% after transhiatal esophagectomy and 20.8% after transthoracic esophagectomy). Among the patients with a high anesthetic risk (ASA III) that underwent surgery, the postoperative mortality was significantly lower after transhiatal esophagectomy (10%) compared to transthoracic esophagectomy (47%) (P <0.05).
Similar articles
-
An audit of surgical outcomes of esophageal squamous cell carcinoma.Eur J Cardiothorac Surg. 2007 Mar;31(3):536-44. doi: 10.1016/j.ejcts.2006.12.002. Epub 2007 Jan 11. Eur J Cardiothorac Surg. 2007. PMID: 17222561
-
Transhiatal versus transthoracic esophagectomy for esophageal cancer.J Thorac Cardiovasc Surg. 1993 Aug;106(2):205-9. J Thorac Cardiovasc Surg. 1993. PMID: 8341062
-
Transthoracic versus transhiatal esophagectomy for esophageal carcinoma: experience from a single tertiary care institution.World J Surg. 2011 Jun;35(6):1296-302. doi: 10.1007/s00268-011-1020-z. World J Surg. 2011. PMID: 21384241
-
Transhiatal esophagectomy.Surg Clin North Am. 2005 Jun;85(3):593-610. doi: 10.1016/j.suc.2005.01.009. Surg Clin North Am. 2005. PMID: 15927654 Review.
-
Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: a meta-analysis.Ann Surg. 2011 Dec;254(6):894-906. doi: 10.1097/SLA.0b013e3182263781. Ann Surg. 2011. PMID: 21785341
Cited by
-
Standardized clinical pathways for esophagectomy are not a reality in Brazil, even with a high prevalence of esophageal cancer and achalasia.Arq Bras Cir Dig. 2015 Jul-Sep;28(3):190-2. doi: 10.1590/S0102-67202015000300011. Arq Bras Cir Dig. 2015. PMID: 26537144 Free PMC article.
-
Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior.Cancers (Basel). 2018 Oct 12;10(10):381. doi: 10.3390/cancers10100381. Cancers (Basel). 2018. PMID: 30322005 Free PMC article. Review.
-
The use of LigaSure Vessel Sealing System in Ivor Lewis esophagectomy.J Cardiothorac Surg. 2012 Jan 24;7:10. doi: 10.1186/1749-8090-7-10. J Cardiothorac Surg. 2012. PMID: 22273539 Free PMC article.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous